K
Katharina Fink
Researcher at Karolinska University Hospital
Publications - 46
Citations - 1531
Katharina Fink is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 13, co-authored 32 publications receiving 1081 citations. Previous affiliations of Katharina Fink include University of Gothenburg & Karolinska Institutet.
Papers
More filters
ReportDOI
Comparing the Safety of Medicines to Treat MS during the COVID-19 Pandemic
Anna Fogdell-Hahn,Simon Englund,Klara Asplund Högelin,Jessica B. Smith,Bonnie H. Li,Joachim Burman,Katharina Fink,Martin Gunnarsson,S. Hillert,Jan Lycke,Petra Nilsson,Jonatan Salzer,Anders Svenningsson,Magnus Vrethem,Tomas Olsson,Ingrid Kockum,Faiez Al Nimer,Elisa Longinetti,Thomas Frisell,Annette Langer-Gould +19 more
Journal ArticleDOI
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
David Leppert,Mitsuru Watanabe,Sabine Schaedelin,Fredrik Piehl,Roberto Furlan,Matteo Gastaldi,Jeremy Lambert,Björn Evertsson,Katharina Fink,Takuya Matsushita,Katsuhisa Masaki,Noriko Isobe,Jun Ichi Kira,Pascal Benkert,Aleksandra Maleska Maceski,Eline A.J. Willemse,J. Oechtering,Annette Orleth,Stephanie Meier,Jens Kuhle +19 more
TL;DR: In this article , granulocyte activation markers (GAM) were used as a biomarker to distinguish neuromyelitis optica spectrum disorder (NMOSD) from multiple sclerosis (MS) and whether levels associated with neurological impairment.
Journal ArticleDOI
MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1‐weighted imaging
Carmen Cananau,Y. Forslin,Åsa Bergendal,Henrik Sjöström,Katharina Fink,Russell Ouellette,Maria Kristoffersen Wiberg,Sten Fredrikson,Tobias Granberg +8 more
TL;DR: In this paper , the authors investigated associations of prior gadolinium administrations with magnetization transfer and T1 signal abnormalities, and found that the associations were associated with a higher risk of adverse effects.
Journal ArticleDOI
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.
Fitsum Sebsibe Teni,Alejandra Machado,Chantelle Murley,Anna He,Katharina Fink,Hanna Gyllensten,Anna Glaser,Kristina Alexanderson,S. Hillert,Emilie Friberg +9 more
TL;DR: In this paper , a longitudinal register-based study was conducted, on a prospective data set linked across six nationwide registers, assessing treatment courses of PwMS with DMTs for the 10 years following multiple sclerosis (MS) onset.
Journal ArticleDOI
Re: Declines in the diagnosis of primary progressive MS—A critical change in phenotype or critical measurement error?:
Helga Westerlind,Leszek Stawiarz,Katharina Fink,Katharina Fink,Jan Hillert,Jan Hillert,Ali Manouchehrinia +6 more
TL;DR: In Faizy’s study, lesions were subdivided into three categories: contrast-enhancing lesions (CEL), black holes (BH) and T2 lesions, which were similar to using T1-signal intensities in the authors' study.